Erick&M.&Carreira& - chemie.uni-konstanz.de€¦ · OBz O O TsO OMOM f. Ac2O, pyr, DMAP; then TBAF...
Transcript of Erick&M.&Carreira& - chemie.uni-konstanz.de€¦ · OBz O O TsO OMOM f. Ac2O, pyr, DMAP; then TBAF...
Erick M. Carreira Gaich Group Seminar Birte Schröder 13.01.14
Prof. Erick M. Carreira
• Born in Havana, Cuba (1963) • EducaFon;
– B. Sc.: University of Illinois at Urbana Champaign (1984) under supervision of Prof. Sco) E. Denmark – PhD.: Harvard University (1990) under supervision of Prof. David A. Evans – PostDoc: California InsFtute of Technology under supervision of Prof. Peter Dervan – Associate professor: California InsFtute of Technology (1996) – Full professor: California InsFtute of Technology (1997)
ETH Zürich (1998-‐now) • Former member: JusFn Du Bois, Teshik P. Yoon, Karl Gademann, Nicolai
Cramer, Tobias Ri\er, Corey Stephenson
2
Prof. Erick M. Carreira
Research Interest: • Asymmetric synthesis by organometallic chemistry • Total synthesis • Medicinal chemistry
3
Methodology
4
O
O
H tBu
hv ∗∗
O
∗∗ ∗∗
O
tBu
Ar
Ar
R
or [M]
Ar CF3
Ar
R
CF3
or
NBn
O N
R2
R1+
cat. MgI2
NBn
O
NR1
R2
XY
+[Ir]
XY
H
R+
X
R R
Zn(OT)2
∗∗
R
X
RR
R
OHX = OR; NH2; NHR; SR; ...
∗∗ R
X
[Ir]
Photochemistry
Cyclopropana2on
Ring expansion
Nitrile oxide cycloaddi2on
Terminal alkyne addi2on
Branched allylic alcohol subs2tu2on
... and many others...
Methodology -‐ Photochemistry
a. Intramolecular [2+2] cycloaddiFon of 1,2-‐disubsFtuted allenes with enones and enoates
5
-‐ use of opFcally acFve allenes (89-‐92%ee) -‐ asymmetric inducFon through the allene fragment (83-‐100%)
Carreira et al. JACS 1994, 116, 6622-‐6630
O
O
H tBu
hv∗∗
O
∗∗ ∗∗
O
tBu
∗∗
O
∗∗ ∗∗
O
O[O]
1 2 3
a. Intramolecular [2+2] PhotocycloaddiFon of 1,2-‐DisubsFtuted Allenes with Enones and Enoates
6 Carreira et al. JACS 1994, 116, 6622-‐6630
Methodology -‐ Photochemistry
O
O
tBu
H O
hv
88%OO
O
tBu
H
92% ee92% ee
O
O
tBu
H O
hv
90%OO
O
tBu
H
92% ee92% ee
TIPSOTIPSO
10 11
12 13
O
H tBu
hv
O
O
HO
tBu
O
HO tBu
+
91% ee 92% ee
O
H tBu
hv
O
O
HO
tBu
O
HO tBu
+
78% ee 74% ee
89%
72%
92% ee
89% ee
4 5 6
7 8 9
b. Asymmetric [2+2] PhotocycloaddiFon with an Allenylsilane
7
• TMS group is used as a removable stereochemical controlling group
Carreira et al. JACS 1997, 119, 2597-‐2605
Scope: • X = O, NBoc • 5-‐ and 6-‐membered rings • Coumarin derivates (X= O, S)
Methodology -‐ Photochemistry
O
X
H TMS
hv
O
X
TMS
Me3SiF
H O
X
H
TBAF/HOAc
14 15 16
O
O
H TMS
O
H TMS
H
kf
krO
SiMe3H
O
O
O
TMS H
kc
14 17 18 19
c. Stereospecific 1,5-‐Hydrogen-‐Atom Transfer
8 c. Carreira et al. JACS 1997, 119, 2597-‐2605 d. Tet. Le\. 1997, 38, 5579-‐5582
Methodology -‐ Photochemistry
d. PhotocycloaddiFon/FragmentaFon ReacFon of Dioxinones
O
O
O
OO
tBu
H
Ph
Ph O
O
O
OO
Ph
Ph
tBuH
H
H
O
O
O
OO
Ph
Ph
H
H
tBu
1,4 - diradical
hv 1,5 H shift
20 21 22
O O OMe Me
OR O
OO O
MeMe
R O
O
R
CO2Me
O O OMe Me
OR
OO O
MeMe
O
R
O
O
R
CO2Me
hv
hv
MeOH/K2CO30°C
MeOH/K2CO30°C
23 24 25
26 27 28
a. Trifluoromethyl-‐subsFtuted Cyclopropanes and Cyclopropenes
9 Carreira et al. Angew. Chem. Int. Ed. 2010, 49, 938 Carreira et al. Angew. Chem. Int. Ed. 2010, 49, 4294
Methodology – Cyclopropanes
Reac:vity of Cyclopropenes
CF3
Ph
CF3
PhPd/CaCO3
H2
Me
Me
Pd(OAc)2p-Br-C6H4NO2K2CO3
BuLi,PhCHO
CF3
Ph
OH
Ph CF3
Ph
NO2
H
Ph
CF3
Me
Me
97%
93%78%
90%
Diels-‐Alder reacEon
reducEon
Heck coupling
lithiaEon and trapping
R2
R1
R1
Ar
F3C NH2 HCl
or
+
[Fe(TPP)Cl] (3mol%)DMAP (10 mol%)NaNO2 (1.8 eq.)
NaOAc (20 mol%)H2SO4 (10 mol%)H2O, r.t., 14 h
R1Ar
CF3Rh2(esp)4 (2.5 mol%)NaNO2 (2.4 eq.)
NaOAc (20 mol%)H2SO4 (10 mol%)H2O, r.t., 14 h
CF3
R1 R2
29
30
31
32 33
c. Iron-‐catalyzed CyclopropanaFons
10
Methodology – Cyclopropanes
Carreira et al. Org. Le\. 2012, 14, 2162-‐2183.
Carreira et al. Org. Le\. 2011, 13, 3080-‐3081.
b. Iron-‐catalyzed PreparaFon of Vinyl-‐and Alkynylcyclopropanes
RFe-catalyst
ClH3N CF3R
R CF3
CF3
R
10 examples52-95 %R = Aryl
35
36
29
37
38
R
COOEt
NH3Cl+
Fe-catalyst
NaNO2/AcOHH2O
COOEtR 10 examples
55-79 %6:1 - 10:1 dr
39 40 41
11
Methodology -‐Cyclopropanes
Carreira et al. Org. Le\. 2012, 14, 1900-‐1901
d. PreparaFon of Trifluoromethyl-‐subsFtuted Aziridines
• Good yields, good diastereoselecFvity • cis-‐subsFtuted aziridine is major product • DeprotecFon w/ CAN gives the free aziridine
N2
CF3+
R
O
NPMB
BF*OEt2 NPMB
CF3R
O
in situ generated
9 examples47-73 %R = Aryl11:1 - 19:1 cis/trans
42 43 44
e. Trifluoroethyl-‐subsFtuted Ketones from Aldehydes and Cyclohexanones
12 Carreira et al. Angew. Chem. Int. Ed. 2011, 50, 9085.
Methodology – Cyclopropanes
MechanisFc studies:
in situ generaEon F3C NH2 HCl
1) NaNO2, 1 h, 0°C, CH2Cl2/H2O (30:1) N2
CF3
ZrCl4, RCHO-78°c, 45 min, CH2Cl2/H2O (30:1)
O
RCF3
ZrCl4, cyclic ketone-78°c, 45 min, CH2Cl2/H2O (30:1)
O CF3
R
29 42
45
46
N2
CF3
O
HR+
ZrCl4R
CF3
N2
Cl4ZrO H
R= alkylHydride migration
R= arylAryl migration
O
RCF3
O
HCF3
R
N2
CF3O
CF3
R
F3C
42 47 48
49
50 51
Ring expansion of Cyclopropanes by Aldimines
13 Carreira et al. Angew. Chem. Int. Ed. 1999, 38, 3186
Methodology – Ring expansion
NBn
O
NBn
OMg
NR1
R2
INBn
O
N
R2
R1
NBn
OMg
I
INBn
O
IN
R2
R1
A
B C
PotenFal mechanisFc pathways leading to the formaFon of the pyrrolidine ring:
NBn
O N
R2
R1+
cat. MgI2
NBn
O
NR1
R2
68-98%<98:2 d.r. N
Bn
O
NR1
R2
+
R1 = alkyl, allyl, Bu, TsR2 = alkyl, Ar, furyl
52 53 54 55
Methodology – Ring expansion
14
ApplicaFons in Total Synthesis
1) (+)-‐SpirotryprostaFn B
2) Strychnofoline
Carreira et al. Angew. Chem. Int. Ed. 1999, 38, 3186. Carreira et al. J. Am. Chem. Soc. 2005, 127, 11505. Carreira et al. Angew. Chem. Int. Ed. 2003, 42, 694.
NNHN
O
OH
(+)-Spirotryprostatin B
PGN
HO
O NH
O
NPG
R1
R2 R3
+NH
O N
R1
PG+
R2 R3
56 57 58 59 60
NBn
OHO
N
HMeN
HN
H
H
NBn
OBnO
N
H
OTBDPSN
TBDPSONBn
O+
BnO
Strychnofoline
61 62 63 64
Prof. Erick M. Carreira
Research Interest: • Asymmetric synthesis by organometallic chemistry • Total synthesis • Medicinal chemistry
15
Total Synthesis
16
NBn
OHO
N
HMeN
HN
H
H
Strychnofoline
HO
Me
OAc
CO2MeN
(+)-daphmanidin E
NNHN
O
OH
(+)-Spirotryprostatin B
MeMe
OCl
MeCl
Gomerone C
NO
O
H i-Pr
Me
Me
(-‐) Dendrobine
17
Total Synthesis of Strychnofoline
Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 3436-‐3439
Key features: • Ring expansion of a spiro-‐[cyclopropan-‐1,3‘-‐
oxindole] and a cyclic imine
SyntheFc Approach:
N
TBDPSONBn
OBnO
HN
HN
+ +
63 64 65
NBn
OHO
N
HMeN
HN
H
H
61
Strychnofoline
NBoc
TBDPSO
Oa. i) PhSeCl, LHMDS, THF, -78°C ii) H2O2, EtOac, rt
NBoc
TBDPSO
O
b. CuBr*SMe2. allyl MgCl, TMSCl
c. i) DiBAl-H ii) HCl (aq.)
NBoc
TBDPSO
d. TMSOTf, NEt3N
TBDPSO66 67 68 63
Strychnofoline
18 Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 3436-‐3439
N
TBDPSO
NBn
O+e. MgI2, THF
BnONBn
OBnO
N
H
f. NMO, OsO4, H2O, dioxane, tBuOH, rt
g. NaIO4, H2O, dioxane, tBuOH, rth. pTsOH, MeOH, CH(OMe)3
ring expansion
OTBDPS
63 64 69
NBn
OBnO
N
H
OTBDPS
CH(OMe)2
i. TBAFj. IBX, DMSOk. tBuOK. Ph3PMeBr
NBn
OBnO
N
H CH(OMe)2NBn
OBnO
N
H CHO
l. 10 % HCl (aq)
707172
Strychnofoline
19 Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 3436-‐3439
NBn
O
N
H CHO
m. N-Methyltryptamine, AcOH, tol, refl.
NBn
OBnO
N
HMeN
HN
H
H
n. Na, NH3, THF,tBuOH, -78 to -45°C
73 74
NH
OHO
N
HMeN
HN
H
H
Strychnofoline 61
Total Synthesis of (+)-‐ Daphmanidin E
20
Retrosynthe2c plan
Key features: • Readily available building block which features two
quaternary centers and the bicyclo[2.2.2]octane skeleton
• Two Claisen rearrangements • Late-‐stage cobalt-‐catalyzed Heck coupling
Carreira et al. Angew. Chem. Int. Ed. 2011, 50, 11501-‐11505
one-‐pot reacFon from diethyl succinate
HO
Me
OAc
CO2MeN
(+)-daphmanidin E
RX
OO
PGO
PGO
PGHN
MeClaisen rearrangement
late-stage alkylHeck coupling
O
OCO2Et
EtO2C
75 76 77
21
(+)-‐ Daphmanidin E
Carreira et al. Angew. Chem. Int. Ed. 2011, 50, 11501-‐11505
O
OCO2Et
EtO2C
a. 1,3-propandiol, pTsOH, 88%b. KHMDS, 2-(NTf2)*pyr, 87%
OTfCO2Et
EtO2COO
c. C3H5OSitBuPh2, 9-BBN, [Pd2(dba)3]/CHCl3 (2mol%), AsPh3 (16mol%), K3PO4, DMF/THF/H2O, 45%
CO2Et
EtO2COO
OTBDPS
d. BH3*SMe2, THF, rt, then NaBO3*4H2O; DiBAl 72%e. pTsOH (5mol%), acetone; then BzCl, pyr, DMAP, 95%
OTBDPS
O
OBzO
O
TsO
OMOM
f. Ac2O, pyr, DMAP; then TBAF 86%
OTBDPS
O
OBzO
O
OMOM
OTBDPS
O
OBzO
O
OMOM
g. 155°C, nonane, d.r. = 10:1, 86%
HH
Claisen rearrangement
77 78 79
808182
22
(+)-‐ Daphmanidin E
Carreira et al. Angew. Chem. Int. Ed. 2011, 50, 11501-‐11505
L1
PPh2
N
Me MeMe
NEt2
O
OBn
OTBDPS
O
OBzO
O
OMOMHH
h. KHMDS, [18]crown-6, allyl bromide, 83%i. o-xylene, 165°C, 40%
OTBDPS
O
OBzO
OOMOMH
O
OBzO
OOMOMH
AcO
m. CeCl3, oxalic acid, 98%n. Me3S/imidazole; then MOMCl, DiPEA; TBAF, THF, rt 90%o. DMP, 99%
O
OBzH OMOMH
AcO
O
MOMO
p. MeNO2 ,NH4OAc, 75 °C, 77%
O
OBzOMOMH
AcO
MOMO
O2N
Henry condensation
q. ZnMe2, [Cu(OTf)]2, L1, 0°C, d.r =1:5,90% comb. yield
O
OBzOMOMH
AcO
MOMO
BocHN
r. Zn, aq NH4Cl,EtOH, 40°c; Boc2O,EtOH, rt, 85%
Me
Claisen rearrangement
j. 9-BBN, THF, rt; then NaBO3*4 H2O, 60%k. Ac2O, pyr, DMAP, CH2Cl2, rt; TBAF*3H2O, THF, rt, 86%l. 2-NO-C6H4SeCN, PBu3, THF, rt; H2O2, pH 7 buffer, CH2Cl2, rt, 94%
Grieco's protocol
82 83 84
858687
23
(+)-‐ Daphmanidin E
Carreira et al. Angew. Chem. Int. Ed. 2011, 50, 11501-‐11505
stoichiometric
110 mol% catalyst, sunlamp, 60°C, MeCN
catalytic25 mol% catalyst, 1.5 eq iPr2NEt,blue LED, 23°C, MeCN
Key step: Late-‐stage cobalt-‐catalyzed alkyl-‐Heck cycliza2on
s. O3, PPh3, CH2Cl2, -78°C; NaBH(OAc)3, AcOH, THF, rt, 72%t. MsCl, Et3N, CH2Cl2, 0°C; NaI, acetone, 76%u. DBU, PhMe, rt, 92%
O
OBzOMOMH
AcO
MOMO
BocHN
Me
87I
O
OBz
O
AcO
MOMO
BocHN
Me
O
AcO
MOMO
BocHN
Me
Co
SnPh3
N
N
N
Me
MeN
N
Me
Me
O
OBz88 89
90
24
(+)-‐ Daphmanidin E
Carreira et al. Angew. Chem. Int. Ed. 2011, 50, 11501-‐11505
Endgame
O
AcO
MOMO
BocHN
Me
O
OBz
a. K2CO3, MeOH, 0°C, 77%b. PCC, CH2Cl2, rt. 92%c. Bn2NH*CF3CO2H (1:1), PhH, 50°C, 77% after 1 recycle
O
MOMO
BocHN
Me
OBz
OH d. NaCN, AcOH, MnO2, MeOH, rt;
K2CO3, MeOH, 45°C; Ac2O, iPr2NEt, DMAP, CH2Cl2, rt
79% over three steps
O
MOMO
BocHN
Me
OAc
CO2Me
e. CF3CO2H, CH2Cl2, rt; NH4Cl, EtOH, 75°C, 56%
MOMO
Me
OAc
CO2MeNf. Ph2BBr, CH2Cl2,
-25°c, 76%
HO
Me
OAc
CO2MeN
(+)-daphmanidin E
89 91 92
9375
25
Total Synthesis of Gomerone C
Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 13066-‐13069
Retrosynthe2c plan
Key features: • Diels-‐Alder cycloaddiFon • γ-‐SelecFve oxidaFon • α-ChlorinaFon • HydrochlorinaFon • Late-‐stage Conia-‐ene reacFon
MeMe
OClO
MeCl
Conia-ene reaction
hydrochlorination
MeMe
TMS
OCl
OTBS
selective oxidation
α-chlorination
H
MeMe O
Me
O
Diels-Aldercycloaddition
Gomerone C
94 95 96
26
Gomerone C
Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 13066-‐13069
Me
Me OMe
TBSO
+
a. Me2AlCl (20 mol%)tol/CH2Cl2 (2:1). -15 °C.
then 0°C, 24h, 69%
H
MeMe O
Me
TBSO b. F3CCO2H, CH2Cl2 rt. 2h, 89%
c. 2-methyl-2-ethyl-1,3-dioxolane, TsOH*H2O (25 mol%)ethylene glycol (12 mol%), rt, 45min, 95%
H
MeMe O
Me
O
O
97 98 99 100
d. phosphazene base P2tBu (3.0 equiv.), F9C4SO2F, DMF,-10°C to rt for 2h; then rt, 24h
e. i) nBuLi, THF, -78°C to rt, 40min;ii) BF3*OEt, -78°C, 10miniii) DMF (3.3 equiv.), 60min, 78%f. Pd/C (10mol%), H2, (1atm), EtOAc, 2h, 84%
g. dimethyl-1-diazo-2-oxopropylphosphonate, K2CO3, MeOH, 88%h. nBuLi, TMSCl, -78°C to rt; then 0.1 M aq. HCl, 92%
H
MeMe
TMS
O
102
H
MeMe
O
O
101O
H
27
Gomerone C
Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 13066-‐13069
H
MeMe
TMS
O
102
i. LDA, THF, -78°C; then PhS(=N-tBu)Cl, 94%
j. TBSOTf, 2,6-lutidine, DCM, 0°Ck. CrO3, 3,5-dimethylpyrazole, DCM, -20°C, 20min
66% over two steps
l. KN(SiMe3)2 (2 eq.) TBSCl (2 eq.), THF, -78°C to rt
m. Bu4NCl3 (2.4 eq.), DCM, -78°C to rt,
51% over two steps
MeMe
TMS
OCl
OTBS n. (MeCN)[(2-biphenyl)di-tert-butylphosphine]Au SbF6, acetone, 45°C, 6h, 65%
MeMe
OCl d. HCl (gas), SnCl4, DCM,
sealed tube, -78°C to rt,5h, 67%
MeMe
OCl
MeClConia-ene reaction
w/ Echavarren's cat.
Gomerone C
O O
104 105 94
MeMe
TMS
OO
28
Total Synthesis of (-‐)-‐Dendrobine
Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 3436-‐3439
Strategy for the construc2on of the core of (-‐)-‐dendrobine
NO
O
H i-Pr
Me
MeC10-N bond formationreduction lactonization
MeO2C
MeMe
O
NMe
Me
R
Stereoselective protonation
Enamineconjugateaddition
Me
MeO2C
MeMe
OHC 3
O
Cascade sequence
106 107 108
(-‐)-‐Dendrobine
29 Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 3436-‐3439
MeTBDPSO
MeO2C OTBS
MeMe
4
112
k. HF*pyrl. PCC, celite
74% over 5 steps
Me
MeO2C
MeMe
OHC 3
O
107
m. BnMeNHn. H2. Pd/C
68%MeO2C
MeMe
O
NH
Me
H
113
h. TEMPO, PhI(OAc)2
i. iPr2NLi, TMSClj. Me3SiCHN2, benzene, MeOH
EtO2C
Me Me
OO Me
Me
a. LiAlH4b. PhCOCl, DMAP, NEt3c. AcOH
d. TBSCl, DMAP, imid.e. HF*pyrf. (COCl)2, Me2SO, NEt3
iPr
OOTBS Li
(CH2)4OTBDPS
g. EtMgBriPr
TBSO
OBz OH OHOTBDPS
4
60% over 6 steps
81%d.r. (anti/syn) = 2.2 : 1
109 110 111
SyntheFc Approach
(-‐)-‐Dendrobine
30 Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 3436-‐3439
(-‐) dendrobine
MeO2C
MeMe
O
NH
Me
H
113
o. PHT, DMAP, THF, rt.
63% MeO2C
MeMe
O
N
Me
H
Br
MeO2C
MeMe
O
NH
Me
H
Br
114 115
MeO2C
MeMe
OMe
NMe
116
p. NaBH4, iPrOH
65%
NO
O
H i-Pr
Me
Me
106
31
Supplementary Slides
32
Daphmanidin ResoluFon via diastereomeric hydrazones
Supplementary Slides
33
Daphmanidin Comins reagent
34
MeMe
TMS
OCl
OTBS n. (MeCN)[(2-biphenyl)di-tert-butylphosphine]Au SbF6, acetone, 45°C, 6h, 65%
MeMe
OClO
MeMe
TMS
OCl
OTBS
[Au]
MeMe
OClO
[Au]
TMS
Gomerone C
Mechanism of Conia-‐ene reacFon:
(-‐)-‐Dendrobine
35 Carreira et al. Angew. Chem. Int. Ed. 2012, 51, 3436-‐3439